These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2704821

  • 1. Chemical shift imaging with paramagnetic contrast material enhancement for improved lesion depiction.
    Simon JH, Szumowski J.
    Radiology; 1989 May; 171(2):539-43. PubMed ID: 2704821
    [Abstract] [Full Text] [Related]

  • 2. Gadolinium-DTPA enhancement of an optic nerve and chiasmal meningioma.
    Haik BG, Zimmerman R, Saint Louis L.
    J Clin Neuroophthalmol; 1989 Jun; 9(2):122-5. PubMed ID: 2526157
    [Abstract] [Full Text] [Related]

  • 3. Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging.
    Dwyer AJ, Frank JA, Doppman JL, Oldfield EH, Hickey AM, Cutler GB, Loriaux DL, Schiable TF.
    Radiology; 1987 May; 163(2):421-6. PubMed ID: 3562821
    [Abstract] [Full Text] [Related]

  • 4. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR, Press GA.
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [Abstract] [Full Text] [Related]

  • 5. Gd-DTPA enhanced high resolution MR imaging of pituitary adenomas.
    Steiner E, Imhof H, Knosp E.
    Radiographics; 1989 Jul; 9(4):587-98. PubMed ID: 2756189
    [Abstract] [Full Text] [Related]

  • 6. [Gadolinium-DTPA combined with a fat suppression technique in studies with magnetic resonance at 0.5 T in soft-tissue neoplasms].
    Battolla L, Zampa V, Mascalchi M, Falaschi F, Bagnolesi P, Tessa C, Paolicchi A, Bartolozzi C.
    Radiol Med; 1994 Oct; 88(4):353-8. PubMed ID: 7997603
    [Abstract] [Full Text] [Related]

  • 7. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
    Unger EC, Winokur T, MacDougall P, Rosenblum J, Clair M, Gatenby R, Tilcock C.
    Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
    [Abstract] [Full Text] [Related]

  • 8. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
    Giovagnoni A, Paci E.
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
    [Abstract] [Full Text] [Related]

  • 9. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, Schwarz W, Müller PK, Bechstein WO, Mack MG, Söllner O, Felix R.
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [Abstract] [Full Text] [Related]

  • 10. [Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology].
    Bradac GB, Riva A, Berger T, Stura G, Duca S.
    Radiol Med; 1988 Jul; 76(1-2):33-7. PubMed ID: 3399707
    [Abstract] [Full Text] [Related]

  • 11. MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique.
    Hendrix LE, Kneeland JB, Haughton VM, Daniels DL, Szumowski J, Williams AL, Mark LP, Czervionke LF.
    AJR Am J Roentgenol; 1990 Oct; 155(4):849-54. PubMed ID: 2119121
    [Abstract] [Full Text] [Related]

  • 12. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
    Stimac GK, Porter BA, Olson DO, Gerlach R, Genton M.
    AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
    [Abstract] [Full Text] [Related]

  • 13. Gadolinium-DTPA enhancement of VX-2 carcinoma of the rabbit kidney on T1 weighted magnetic resonance images.
    Yancey JM, Ackerman N, Kaude JV, Googe RE, Fitzsimmons JR, Scott KN, Mancuso AA, Hackett RL, Hager DA, Caballero S.
    Acta Radiol; 1987 Dec; 28(4):479-82. PubMed ID: 2958067
    [Abstract] [Full Text] [Related]

  • 14. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Hamm B, Laniado M, Saini S.
    Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
    [Abstract] [Full Text] [Related]

  • 15. [Gd-DTPA in the MR diagnosis of pituitary adenomas].
    Steiner E, Wimberger D, Imhof H, Knosp E, Hajek P.
    Rofo; 1989 Mar; 150(3):323-7. PubMed ID: 2538883
    [Abstract] [Full Text] [Related]

  • 16. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
    Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, Hesse T, Berns T, Peters PE.
    Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
    [Abstract] [Full Text] [Related]

  • 17. Magnetic resonance imaging of local soft tissue inflammation using gadolinium-DTPA.
    Paajanen H, Brasch RC, Schmiedl U, Ogan M.
    Acta Radiol; 1987 Apr; 28(1):79-83. PubMed ID: 2952148
    [Abstract] [Full Text] [Related]

  • 18. Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.
    Haughton VM, Rimm AA, Czervionke LF, Breger RK, Fisher ME, Papke RA, Hendrix LE, Strother CM, Turski PA, Williams AL.
    Radiology; 1988 Mar; 166(3):829-33. PubMed ID: 3340779
    [Abstract] [Full Text] [Related]

  • 19. [MRT of bladder carcinoma: tumor staging and gadolinium contrast behavior].
    Doringer E, Joos H, Forstner R, Schmoller H.
    Rofo; 1991 Apr; 154(4):357-63. PubMed ID: 1850149
    [Abstract] [Full Text] [Related]

  • 20. Benign extraaxial tumors: contrast enhancement with Gd-DTPA.
    Breger RK, Papke RA, Pojunas KW, Haughton VM, Williams AL, Daniels DL.
    Radiology; 1987 May; 163(2):427-9. PubMed ID: 3031727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.